398 related articles for article (PubMed ID: 19650170)
21. Treatment of brain metastases in patients with HER2+ breast cancer.
Bravo Marques JM
Adv Ther; 2009 Jul; 26 Suppl 1():S18-26. PubMed ID: 19669638
[TBL] [Abstract][Full Text] [Related]
22. Occult brain metastases in HER2-positive breast cancer patients: frequency and response to radiotherapy.
Niwińska A; Tacikowska M; Pieńkowski T
Acta Oncol; 2007; 46(7):1027-9. PubMed ID: 17851845
[No Abstract] [Full Text] [Related]
23. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
[TBL] [Abstract][Full Text] [Related]
24. Can we consider always an esophageal carcinoma as radiation associated cancer after irradiation for breast cancer?
Kirova YM; Asselain B; Fourquet A;
Am J Clin Oncol; 2009 Apr; 32(2):197-9. PubMed ID: 19346814
[TBL] [Abstract][Full Text] [Related]
25. HER2 status in bilateral breast cancer.
Crowe JP; Patrick RJ; Rybicki LA; Budd GT; Escobar PF; Tubbs RR; Hicks DG
Int J Fertil Womens Med; 2006; 51(5):219-23. PubMed ID: 17269588
[TBL] [Abstract][Full Text] [Related]
26. Relationship between HER2 status and prognosis in women with brain metastases from breast cancer.
Xu Z; Marko NF; Chao ST; Angelov L; Vogelbaum MA; Suh JH; Barnett GH; Weil RJ
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e739-47. PubMed ID: 22024205
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer brain metastases.
Cheng X; Hung MC
Cancer Metastasis Rev; 2007 Dec; 26(3-4):635-43. PubMed ID: 17717635
[TBL] [Abstract][Full Text] [Related]
28. Letter to the editor. Women with HER2-positive metastatic breast cancer have significantly longer survival after diagnosis of brain metastasis(BM) than those with HER2-negative disease.
Kilickap S; Arslan C
Am J Clin Oncol; 2009 Apr; 32(2):226. PubMed ID: 19346820
[No Abstract] [Full Text] [Related]
29. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.
Palmieri D; Bronder JL; Herring JM; Yoneda T; Weil RJ; Stark AM; Kurek R; Vega-Valle E; Feigenbaum L; Halverson D; Vortmeyer AO; Steinberg SM; Aldape K; Steeg PS
Cancer Res; 2007 May; 67(9):4190-8. PubMed ID: 17483330
[TBL] [Abstract][Full Text] [Related]
30. Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.
Gårdmark T; Wester K; De la Torre M; Carlsson J; Malmström PU
BJU Int; 2005 May; 95(7):982-6. PubMed ID: 15839918
[TBL] [Abstract][Full Text] [Related]
31. Cell proliferation index predicts relapse of brain metastases in non-irradiated patients.
Peev NA; Tonchev AB; Penkowa M; Kalevski SK; Haritonov DG; Chaldakov GN
Acta Neurochir (Wien); 2008 Oct; 150(10):1043-8; discussion 1048. PubMed ID: 18773139
[TBL] [Abstract][Full Text] [Related]
32. Clinical and pathological response to primary chemotherapy in patients with locally advanced breast cancer grouped according to hormonal receptors, Her2 status, grading and Ki-67 proliferation index.
Miglietta L; Vanella P; Canobbio L; Parodi MA; Guglielmini P; Boccardo F
Anticancer Res; 2009 May; 29(5):1621-5. PubMed ID: 19443376
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of and quality assurance in HER2 analysis in breast carcinomas from patients registered in Danish Breast Cancer Group (DBCG) in the period of 2002-2006. A nationwide study including correlation between HER-2 status and other prognostic variables.
Rasmussen BB; Andersson M; Christensen IJ; Møller S
Acta Oncol; 2008; 47(4):784-8. PubMed ID: 18465349
[TBL] [Abstract][Full Text] [Related]
34. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
[TBL] [Abstract][Full Text] [Related]
35. Brain metastases in patients with breast cancer: new horizons.
Kirsch DG; Loeffler JS
Clin Breast Cancer; 2005 Jun; 6(2):115-24. PubMed ID: 16001989
[TBL] [Abstract][Full Text] [Related]
36. Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine.
Zulkowski K; Kath R; Semrau R; Merkle K; Höffken K
J Cancer Res Clin Oncol; 2002 Feb; 128(2):111-3. PubMed ID: 11862482
[TBL] [Abstract][Full Text] [Related]
37. [Metastatic brain tumor in the elderly].
Kawahata N; Ohtomo E
Rinsho Shinkeigaku; 1989 Sep; 29(9):1106-9. PubMed ID: 2598535
[TBL] [Abstract][Full Text] [Related]
38. Burden of breast cancer with brain metastasis: a French national hospital database analysis.
Benjamin L; Cotté FE; Mercier F; Vainchtock A; Vidal-Trécan G; Durand-Zaleski I
J Med Econ; 2012; 15(3):493-9. PubMed ID: 22304337
[TBL] [Abstract][Full Text] [Related]
39. Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T.
Sjøbakk TE; Johansen R; Bathen TF; Sonnewald U; Kvistad KA; Lundgren S; Gribbestad IS
BMC Cancer; 2007 Jul; 7():141. PubMed ID: 17662122
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer scalp metastasis as first metastatic site after scalp cooling: two cases of occurrence after 7- and 9-year follow-up.
Lemieux J; Desbiens C; Hogue JC
Breast Cancer Res Treat; 2011 Jul; 128(2):563-6. PubMed ID: 21431870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
